Evaluation of Evolocumab (AMG 145) Efficacy in Diabetic Adults With Hypercholesterolemia/Mixed Dyslipidemia
Clinical trial NCT02739984 · COMPLETED
Trial details
- NCT number
- NCT02739984
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-17
- Primary completion
- 2017-08-03
- Enrollment
- 424
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.